BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14656217)

  • 1. Can mild-to-moderate hyperhomocysteinaemia impair endothelial function in the absence of other risk factors for cardiovascular disease?
    Honing ML; Stehouwer CD
    Clin Sci (Lond); 2004 Apr; 106(4):345-6. PubMed ID: 14656217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease.
    Wilcken DE
    J Cardiovasc Risk; 1998 Aug; 5(4):217-21. PubMed ID: 9919468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Homocysteine, folic acid, group B vitamins and cardiovascular risk].
    Blacher J; Czernichow S; Horrellou MH; Conad J; David P; Chadefaux-Vekemans B; Ankria A; Galan P; Hercberg S; Ducimetière P
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):145-52. PubMed ID: 15787307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia.
    Spoelstra-de MA; Brouwer CB; Terheggen F; Bollen JM; Stehouwer CD; Smulders YM
    Neth J Med; 2004; 62(7):246-53. PubMed ID: 15554600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of low and high dose folic acid on endothelial dysfunction in a murine model of mild hyperhomocysteinaemia.
    Clarke ZL; Moat SJ; Miller AL; Randall MD; Lewis MJ; Lang D
    Eur J Pharmacol; 2006 Dec; 551(1-3):92-7. PubMed ID: 17045583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate, homocysteine, endothelial function and cardiovascular disease.
    Moat SJ; Lang D; McDowell IF; Clarke ZL; Madhavan AK; Lewis MJ; Goodfellow J
    J Nutr Biochem; 2004 Feb; 15(2):64-79. PubMed ID: 14972346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of the association between plasma homocysteine and atherothrombotic disease: insights from studies of vascular structure and function.
    Stehouwer CD
    Clin Chem Lab Med; 2001 Aug; 39(8):705-9. PubMed ID: 11592437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia and atherothrombotic disease.
    de Jong SC; van den Berg M; Rauwerda JA; Stehouwer CD
    Semin Thromb Hemost; 1998; 24(4):381-5. PubMed ID: 9763355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
    Austin RC; Lentz SR; Werstuck GH
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus and hyperhomocysteinemia.
    van Guldener C; Stehouwer CD
    Semin Vasc Med; 2002 Feb; 2(1):87-95. PubMed ID: 16222599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease.
    Sainani GS; Sainani R
    J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
    De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D
    Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation.
    Chia S; Wilson R; Ludlam CA; Webb DJ; Flapan AD; Newby DE
    Clin Sci (Lond); 2005 Jan; 108(1):65-72. PubMed ID: 15367100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis.
    Malerba M; Gisondi P; Radaeli A; Sala R; Calzavara Pinton PG; Girolomoni G
    Br J Dermatol; 2006 Dec; 155(6):1165-9. PubMed ID: 17107384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible hypertension following coeliac disease treatment: the role of moderate hyperhomocysteinaemia and vascular endothelial dysfunction.
    Lim PO; Tzemos N; Farquharson CA; Anderson JE; Deegan P; MacWalter RS; Struthers AD; MacDonald TM
    J Hum Hypertens; 2002 Jun; 16(6):411-5. PubMed ID: 12037696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ageing endothelium, cardiovascular risk and disease in man.
    Versari D; Daghini E; Virdis A; Ghiadoni L; Taddei S
    Exp Physiol; 2009 Mar; 94(3):317-21. PubMed ID: 18805864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and endothelial function in human studies.
    Moat SJ; McDowell IF
    Semin Vasc Med; 2005 May; 5(2):172-82. PubMed ID: 16047269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and large arteries.
    Guldener CV; Stehouwer CDA
    Adv Cardiol; 2007; 44():278-301. PubMed ID: 17075216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of vascular function in hyperhomocysteinaemia: relationship to atherothrombotic disease.
    Stehouwer CD; Jakobs C
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S107-11. PubMed ID: 9587036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.